- Report
- July 2026
- 197 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,024GBP
- Report
- July 2026
- 182 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,024GBP
- Report
- August 2025
- 194 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,024GBP
- Report
- September 2025
Global
From €4396EUR$4,900USD£3,762GBP
- Report
- April 2026
Global
From €4396EUR$4,900USD£3,762GBP
- Report
- January 2026
Global
From €4396EUR$4,900USD£3,762GBP
- Report
- May 2026
- 139 Pages
Global
From €2691EUR$2,999USD£2,302GBP
€3588EUR$3,999USD£3,070GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,447GBP
- Report
- August 2026
- 271 Pages
Global
From €5248EUR$5,850USD£4,491GBP
- Report
- August 2026
- 383 Pages
Global
From €5248EUR$5,850USD£4,491GBP

The Autoimmune Disorder market is a subset of the Allergy and Immunology field. It focuses on the diagnosis and treatment of diseases caused by an overactive immune system. These diseases can affect any organ or tissue in the body, and can range from mild to life-threatening. Common autoimmune disorders include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment typically involves medications to suppress the immune system, as well as lifestyle changes to reduce inflammation.
The Autoimmune Disorder market is highly competitive, with many companies offering treatments and therapies. These include pharmaceutical companies such as AbbVie, Amgen, and Biogen, as well as biotechnology companies such as Gilead Sciences and Celgene. Additionally, there are a number of smaller companies that specialize in specific autoimmune disorders, such as Mylan and Alexion Pharmaceuticals. Show Less Read more